Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDDate | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
10/17/2024 | Q3 2024 | $4.36 | $45.15 B | |||
07/17/2024 | Q2 2024 | $9.91 | $43.65 B | |||
04/18/2024 | Q1 2024 | $9.65 | $42.58 B | |||
02/21/2024 | Q4 2023 | $3.67 | $42.65 B | |||
10/18/2023 | Q3 2023 | $5.48 | $42.85 B | |||
07/19/2023 | Q2 2023 | $7.83 | $43.67 B | |||
04/19/2023 | Q1 2023 | $8.37 | $42.17 B | |||
02/15/2023 | Q4 2022 | $3.99 | $39.93 B | |||
10/19/2022 | Q3 2022 | $6.75 | $39.94 B | |||
07/20/2022 | Q2 2022 | $7.72 | $6.87 | -0.85 | $38.63 B | |
04/20/2022 | Q1 2022 | $7.81 | $7.48 | -0.33 | $38.10 B | |
02/16/2022 | Q4 2021 | $4.70 | $36.58 B | |||
10/20/2021 | Q3 2021 | $6.37 | $6.20 | -0.17 | $35.82 B | |
07/21/2021 | Q2 2021 | $6.33 | $7.33 | 1 | $33.85 B | |
04/21/2021 | Q1 2021 | $6.51 | $6.80 | 0.29 | $32.39 B | |
02/18/2021 | Q4 2020 | $2.23 | $31.82 B | |||
10/28/2020 | Q3 2020 | $4.15 | $0.88 | -3.27 | $31.16 B | |
07/29/2020 | Q2 2020 | $8.88 | $9.02 | 0.14 | $29.26 B | |
04/29/2020 | Q1 2020 | $6.48 | $6.03 | -0.45 | $29.62 B | |
02/19/2020 | Q4 2019 | $3.69 | $27.41 B |
The conference call for Elevance Health Inc.'s latest earnings report can be listened to online.
The conference call transcript for Elevance Health Inc.'s latest earnings report can be read online.
Elevance Health Inc. (:ANTM) has a recorded annual revenue of $171.34 B.
Elevance Health Inc. (:ANTM) has a recorded net income of $171.34 B. Elevance Health Inc. has generated $25.69 earnings per share over the last four quarters.
Elevance Health Inc. (:ANTM) has a price-to-earnings ratio of 13.99 and price/earnings-to-growth ratio is -3.59.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED